{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/0378-5440#drug","name":"Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0378-5440"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA208452"},{"@type":"PropertyValue","propertyID":"UNII","value":"G70B4ETF4S|212WAX8KDD|OTT9J7900I"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"d9a4185e-43fa-4aeb-9b0f-8db01b166038"}],"activeIngredient":"EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR DISOPROXIL FUMARATE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"Mylan Pharmaceuticals Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/ANDA208452","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9a4185e-43fa-4aeb-9b0f-8db01b166038","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-5440"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-28T08:23:04.629Z"}}